CIDRAP newsletters options
A systematic review and meta-analysis of randomized controlled trials examining antibiotic therapy for non-recurrent Clostridium difficile infections has found that fidaxomicin provides a sustained symptomatic cure most frequently, researchers reported yesterday in The Lancet Infectious Diseases.
A phase 3 study of the novel antiviral baloxavir marboxil suggests that it reduces symptoms in people at high risk of flu complications, Roche announced today.
Almost half of patients with respiratory infections improperly get antibiotics.
A report summing up all the investigation findings in India's Nipah virus outbreak says 17 of 19 patients appear to have contracted the virus from the index patient, a 26-year-old man, Press Trust of India (PTI) reported yesterday, citing findings released by health officials from Kerala state.
Federal health officials are investigating a Vibrio parahaemolyticus outbreak linked to fresh crab meat imported from Venezuela that has sickened 12 people in three states and the District of Columbia.
More cases have been reported in 2 outbreaks, one linked to Del Monte veggie trays and the other to McDonald's salads.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Jul 12
With 27 new infections, the case count in a multistate Salmonella Mbandaka outbreak tied to Kellog's Honey Smacks cereal has reached 100 cases, the Centers for Disease Control and Prevention (CDC) said yesterday in an update.
Two more states—Florida (2 cases) and Colorado (1)—have reported cases, bringing the number of affected states to 33. The CDC first reported the outbreak to the public on Jun 14.
The US Food and Drug Administration (FDA) today approved TPOXX (tecovirimat), made by SIGA Technologies, as the first drug with an indication for treating smallpox, a disease that has been eradicated but could still be used as a bioweapon.
The decision means the firm will no longer work on several antimicrobial projects in development.
BARDA will provide $24 million in initial funds to 2 companies to advance tests for influenza A and B.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, today announced the formation of a new task force to address drug shortages and long-term strategies for preventing them.
A new study by researchers with a health system in Detroit indicates that a small, behavioral "nudge" in microbiology reporting increased de-escalation and discontinuation of unnecessary broad-spectrum antibiotics in pneumonia patients. The results were reported in Open Forum Infectious Diseases.
Depression, headaches, and insomnia are just some of the often debilitating symptoms.
"Our results justify consideration for revised recommendations from WHO and wider use of bedaquiline," the authors write.
Researchers today reported a case series of four babies with congenital Zika infections who were born with right unilateral diaphragmatic paralysis, suggesting that the virus can cause additional damage in the peripheral nervous system. A team from the Mayo Clinic and Brazil published its findings in Emerging Infectious Diseases.
The US Food and Drug Administration (FDA) yesterday announced that it is updating the labels for fluoroquinolone antibiotics to strengthen warnings about the risk of mental health side effects and reduced blood sugar.
Among the findings: abundant acorns and few predators of rodents help boost tick levels.
The UK Department of Health and Social Care (DHSC) yesterday announced the launch of a £10 million ($13 million) research competition to fund innovative efforts to combat antimicrobial resistance (AMR).
A new report from the World Health Organization's (WHO's) Eastern Mediterranean regional office shows four more MERS- CoV cases reported by Saudi Arabia in June, one of them fatal.
The WHO said none of the four cases of appears to be in a cluster. In late May, Saudi officials identified clusters of cases in Najran and Jeddah linked to household outbreaks.
